⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 24, 2024International Journal of OphthalmologyOpen Access

Intravitreal conbercept injection with panretinal photocoagulation for high-risk proliferative diabetic retinopathy with vitreous hemorrhage

Yao Xu Wei Shen

View Full Paper

Ask AI

Bookmark

Share

Abstract

To assess the clinical efficacy and safety of combining panretinal photocoagulation (PRP) with intravitreal conbercept (IVC) injections for patients with high-risk proliferative diabetic retinopathy (HR-PDR) complicated by mild or moderate vitreous hemorrhage (VH), with or without diabetic macular edema (DME).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Xu et al. (2024) studied this question.

synapsesocial.com/papers/68e68981b6db643587611994 https://doi.org/10.18240/ijo.2024.06.11

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Comparison of the Efficacy and Safety of Conbercept Plus Panretinal Photocoagulation Versus Panretinal Photocoagulation Alone for Proliferative Diabetic Retinopathy: A Multicenter, Prospective, Randomized Controlled StudyRCT · 2026
2Outcomes of intravitreal anti-VEGF injections and panretinal photocoagulation in preretinal hemorrhage secondary to proliferative diabetic retinopathy involving the fovea2024
3Efficacy and safety of intravitreal injection of conbercept for moderate to severe nonproliferative diabetic retinopathy2024 · 2 citations
4Pan Retinal Photocoagulation VS Intravitreal Injection of Anti-VEGF in Treatment of Proliferative Diabetic RetinopathyOriginal Research · 2025
5Real-world effect of vitrectomy combined with intravitreal conbercept for treatment of vitreous haemorrhage in proliferative diabetic retinopathy (QILIN I): a prospective cohort studyCohort Study · 2026